基本信息
浏览量:0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Curriculum Vitae
Name: Di GU
Birth place: Guangzhou City, China
Hospital in china: Guangzhou Medical University
The first affiliated Hospital
Email address: sveong@163.com
GMC no: 7487712
Mobile phone: 18819378495
He is currently an consultant urological surgeon, associated professor, Vice Head of the Department of Urology in the first affiliated hospital of Guangzhou medical university (GMU). After graduating MBBS from the Southern Medical University, Di completed his Masters in Biomedicine and Molecular Science in Kings’ College London. He finished his residency program in Nanfang Hospital and obtained his PhD degree in the Southern Medical University in Guangzhou in 2013. At the same year, he won a Chinese national selection and became the first international trainee selected by the Royal College of Surgeons of Edinburgh from China. He was then worked in Kings College Hospital London as a senior clinical fellow and a robotic fellow in University College Hospital London. He went back to China in 2019 and built up the urological robotic team in the first affiliated hospital in GMU since then.
Education: Doctor of Surgery (Distinction) 2010.9~2013.7
School of Clinical Medicine, Southern Medical University (SMU)
Master of Science (Merit) 2007.9~2008.7
Biomedicine and Molecular Science, King’s college London (KCL)
Bachelor of Medicine (Distinction) 2002.9~2007.7
School of Clinical Medicine, Southern Medical University (SMU)
Work Experience: Associated Consultant in Urology 2019.01 till now
The first affiliated hospital of Guangzhou Medical Univerisity
Robotic Clinical Fellow 2017.11 -2018.11
Department of Urology, University College Hospital, London
Senior Clinical Fellow 2016.10~2017.10
Department of Urology, Kings College Hospital, London
Fellowship, Urology 2012.7~2016.9
Department of Urology, Nanfang Hospital, SMU
Resident training, Surgery 2008.9~2012.7
Nanfang Hospital, SMU
Qualification certificate of Speciality and Technology
Attending surgeon in Urology in china NO. 12140091 DATE: 27th May 2012
Associated Consultant in Urology in China NO.440111198312033016 Date: April 2015
Title of graduate theses:
MSc: “Cytokines Potentiate Free Radical Generation by Bradykinin via NADPH Oxidase in RBE4 cells”
PhD: “The study of the pathogenesis of ketamine cystitis.”
PUBLICATIONS:
1、Di Gu, Jun Huang, Peng Wu. “Effects of long-term ketamine administration on rat bladder protein levels: A proteomic investigation using two-dimensional difference gel electrophoresis system” International Journal of Urology (2013), doi: 10.1111/iju.12100.
2、Di Gu, Jun Huang, Youle Yin, Zhengfei Shan, Shaobin Zheng, Peng Wu. “Long-term ketamine abuse induces cystitis in rats by impairing the bladder epithelial barrier” Molecular Biology Reports, 2014, doi: 10.1007/s11033-014-3616-5
3、Guangzheng Lin1*, Ling Ning2*, Di Gu1*, Shi Li1, Zhe Yu1, Qicheng Long1, Li-Na Hou3,
Wan-Long Tan1. Examining the association of circulating 25-hydroxyvitamin D with kidney cancer risk: a meta-analysis; Int J Clin Exp Med 2015;8(11):20499-20507
4、Xie G*, Gu D*, Zhang L, Chen S, Wu D. A rapid and systemic complete response to stereotactic body radiation therapy and pembrolizumab in a patient with metastatic renal cell carcinoma; Cancer Biology & Therapy. 2017. doi:10.1080/15384047.2017.1345389
5、CHEN Shijun1, GU Di1, L.J. TAY2, Robert GRAY2, JING Tao3, CHEN Dingnan1, ZHENG Shaobin1, Peter THOMPSON2;The history of tranditional Chinese medicine and its current role in urolithiasis 2016.4.;
6、Chen, Y. , Gu, D. , Wen, Y. , Yang, S. , Duan, X. , Lai, Y. , Yang, J. , Yuan, D. , Khan, A. , Wu, W. , & Zeng, G. Identifying the novel key genes in renal cell carcinoma by bioinformatics analysis and cell experiments. Cancer cell international, 2020, 20(1): 1-16.DOI: 10.1186/s12935-020-01405-6
7、Wu, X. , Lv, D. , Lei, M. , Cai, C. , Zhao, Z. , Eftekhar, M. , Gu, D. , & Liu, Y. A 10-gene signature as a predictor of biochemical recurrence after radical prostatectomy in patients with prostate cancer and a Gleason score ≥7. Oncology letters, 2020, 20(3): 2906-2918. DOI: 10.3892/ol.2020.11830
研究兴趣
论文共 57 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Ruiyue Zhao,Miao Ke,Jie Lv,Shaoyu Liu, Yuheng Liu,Jing Zhang, Lifu Xu,Di Gu,Mingzhao Li,Chao Cai,Yongda Liu,Guohua Zeng,
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGno. 6 (2024): 1753-1762
Ruiyue Zhao, Zeheng Xia,Miao Ke,Jie Lv, Huizhen Zhong, Yulu He,Di Gu,Yongda Liu,Guohua Zeng,Lin Zhu,David Alexoff,Hank F. Kung,
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2024)
Asian Journal of Surgery (2024)
Ruiyue Zhao, Zeheng Xia,Miao Ke,Jie Lv, Huizhen Zhong, Yulu He,Di Gu,Yongda Liu,Guohua Zeng,Lin Zhu,David Alexoff,Hank F Kung,
European journal of nuclear medicine and molecular imagingno. 7 (2024): 2124-2133
Ruiyue Zhao,Miao Ke,Jie Lv,Shaoyu Liu, Yuheng Liu, Jing Zhang, Lifu Xu,Di Gu,Mingzhao Li,Chao Cai,Yongda Liu,Guohua Zeng,
European Journal of Nuclear Medicine and Molecular Imagingpp.1-10, (2024)
Otaš Durutovic,Guohua Zeng,Bhaskar Somani,Simon Choong,Giorgio Mazzon,Di Gu,Zeeshan Hameed, Rajeev Tp,Bogomir Milojevic,Davide Brusa, Tiago Ribeiro Oliveira, Sergio Pereira,
Asian Journal of Urology (2024)
Acta Pharmaceutica Sinica Bno. 4 (2024): 1661-1676
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn